S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
TSE:HEXO

HEXO - HEXO Stock Forecast, Price & News

C$2.11
-0.07 (-3.21%)
(As of 01/27/2023 08:57 PM ET)
Add
Compare
Today's Range
C$2.07
▼
C$2.19
50-Day Range
C$0.16
▼
C$2.22
52-Week Range
C$1.23
▼
C$13.16
Volume
587,966 shs
Average Volume
327,764 shs
Market Capitalization
C$90.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$0.54

HEXO stock logo

About HEXO (TSE:HEXO) Stock

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

Receive HEXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

HEXO Stock News Headlines

January 20, 2023 | finance.yahoo.com
HEXO Corp. Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 15, 2023 | fool.com
HEXO Corp. (TSX: HEXO)
January 30, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
November 16, 2022 | seekingalpha.com
Entourage Health Corp. (ETRGF) Q3 2022 Earnings Call Transcript
November 16, 2022 | msn.com
Entourage Health Stock Slightly Up On Earnings And Supply Agreement With HEXO
November 15, 2022 | finance.yahoo.com
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
October 26, 2022 | msn.com
The Best 7 Cannabis Penny Stocks To Buy For %currentmonth% %currentyear%
October 15, 2022 | msn.com
Cannabis Stock Movers For October 14, 2022
January 30, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
October 7, 2022 | uk.investing.com
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session By Benzinga - Investing.com UK
October 7, 2022 | uk.investing.com
Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket By Benzinga - Investing.com UK
October 7, 2022 | benzinga.com
Thinking about buying stock in Invivo Therapeutics, Credit Suisse, Hexo, Payoneer Global, or DexCom? - Cr - Benzinga
September 28, 2022 | morningstar.com
Cannabis vape maker Left Coast Extracts is aiming to expand its California appeal to more states - Morningstar
September 28, 2022 | morningstar.com
Canopy Growth sells retail operations but likely got much less than it paid for them, analyst says - Morningstar
August 31, 2022 | streetinsider.com
HEXO to Produce Mike Tyson's New Cannabis Brand, TYSON 2.0, in Canada - StreetInsider.com
August 30, 2022 | globenewswire.com
HEXO to Produce Mike Tyson's New Cannabis Brand, TYSON 2.0, - GlobeNewswire
August 23, 2022 | reuters.com
HEXO.TO - Hexo Corp | Stock Price & Latest News | Reuters
August 17, 2022 | seekingalpha.com
Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatter - Seeking Alpha
July 28, 2022 | globenewswire.com
Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results - GlobeNewswire
July 26, 2022 | seekingalpha.com
Perlmutter sees Senate cannabis legalization bill as opening for marijuana banking - Seeking Alpha
July 21, 2022 | benzinga.com
This Analyst Expects Stabilization Across Canadian Cannabis Market, Revises Sales Estimates For Cannabis - Benzinga
July 20, 2022 | seekingalpha.com
TLRY, ACB stocks rally as Senate meeting reignites legalization hopes (NASDAQ:TLRY) - Seeking Alpha
July 15, 2022 | seekingalpha.com
With Tilray's $155M investment in HEXO, Roth Capital sees cannabis headwinds and softness - Seeking Alpha
July 6, 2022 | benzinga.com
Thinking about buying stock in Resolute Forest Products, Hexo Corp, Rocket Companies, Aytu Biopharma, or Kazia Therapeutics? - Benzinga
July 6, 2022 | investorplace.com
HEXO Stock Soars 7% After Shareholders Approve Tilray Transaction - InvestorPlace
June 30, 2022 | fool.com
Sundial Growers Has Another Acquisition Target in Its Crosshairs - The Motley Fool
June 28, 2022 | investing.com
Are Any Pot Stocks A Buy Anymore? - Investing.com
See More Headlines
Receive HEXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:HEXO
CUSIP
N/A
CIK
N/A
Web
hexo.com
Phone
844-406-1852
Fax
N/A
Employees
2,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$0.54
High Stock Price Forecast
C$0.80
Low Stock Price Forecast
C$0.25
Forecasted Upside/Downside
-74.5%
Consensus Rating
Hold
Rating Score (0-4)
1.80
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.18
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
80.18
Current Ratio
0.81
Quick Ratio
0.40

Sales & Book Value

Annual Sales
C$191.10 million
Price / Sales
0.47
Cash Flow
C$1.36 per share
Price / Cash Flow
1.55
Book Value
C$0.52 per share
Price / Book
4.04

Miscellaneous

Outstanding Shares
42,928,000
Free Float
N/A
Market Cap
C$90.58 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Mark Attanasio (Age 46)
    Exec. Chairman
  • Mr. Charlie Bowman
    Pres & CEO
  • Mr. Julius Ivancsits
    Chief Financial Officer
  • Mr. Richard Redekop
    VP of Cultivation & Operations
  • Jennifer Smith
    Mang. of Financial Reporting & Investor Relations
  • Mr. Max Cyr
    Director of Customer Experience & Compliance
  • Ms. Joelle Maurais
    Gen. Counsel & Corp. Sec.
  • Ms. Isabelle Dominique Robillard
    VP of Communication
  • Ms. Sonia Isabel
    VP of Sales & Commercial Marketing
  • Mona Matta
    VP of People & Culture

Key Competitors

View All Competitors













HEXO Stock - Frequently Asked Questions

Should I buy or sell HEXO stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last twelve months. There are currently 1 sell rating and 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HEXO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HEXO, but not buy additional shares or sell existing shares.
View HEXO analyst ratings or view top-rated stocks.

What is HEXO's stock price forecast for 2023?

4 analysts have issued 1-year price objectives for HEXO's shares. Their HEXO share price forecasts range from C$0.25 to C$0.80. On average, they expect the company's share price to reach C$0.54 in the next twelve months. This suggests that the stock has a possible downside of 74.5%.
View analysts price targets for HEXO or view top-rated stocks among Wall Street analysts.

How have HEXO shares performed in 2023?

HEXO's stock was trading at C$1.39 at the beginning of the year. Since then, HEXO shares have increased by 51.8% and is now trading at C$2.11.
View the best growth stocks for 2023 here.

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (WEED), Tilray (TLRY), Alibaba Group (BABA), Green Organic Dutchman (TGOD), Curaleaf (CURLF) and

What is HEXO's stock symbol?

HEXO trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HEXO."

How do I buy shares of HEXO?

Shares of HEXO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is HEXO's stock price today?

One share of HEXO stock can currently be purchased for approximately C$2.11.

How much money does HEXO make?

HEXO (TSE:HEXO) has a market capitalization of C$90.58 million and generates C$191.10 million in revenue each year.

How many employees does HEXO have?

The company employs 2,021 workers across the globe.

How can I contact HEXO?

HEXO's mailing address is 3000 Solandt Road, Ottawa, Ontario K2K 2X2. The official website for the company is hexo.com. The company can be reached via phone at 844-406-1852.

This page (TSE:HEXO) was last updated on 1/30/2023 by MarketBeat.com Staff